Implant could block opioid cravings for months
Disease control
Not yet recruiting
This study is testing the safety of a biodegradable implant that slowly releases naltrexone, a medication that blocks the effects of opioids. The implant is placed under the skin of the abdomen and is designed to help people with opioid addiction stay in recovery by preventing re…
Phase: PHASE2 • Sponsor: Go Medical Industries Pty Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC